Key result
Cannabidiol reduced doxorubicin-induced myocardial injury, oxidative stress, and apoptosis in both in vitro and in vivo models by regulating the Hippo signaling pathway.
Why the study?
Doxorubicin has non-negligible cardiotoxicity, and while cannabidiol has reported cardioprotective effects, its protective actions and downstream molecular mechanisms against doxorubicin-induced myocardial injury required evaluation.
Does cannabidiol prevent doxorubicin-induced myocardial injury in preclinical models?
Does cannabidiol prevent doxorubicin-induced myocardial injury in preclinical models?
Answers are grounded in this paper and cite their sources.
Cannabidiol demonstrates cardioprotective effects against doxorubicin-induced myocardial injury in preclinical models by modulating the Hippo signaling pathway.
Background: Doxorubicin (DOX) is a chemotherapeutic agent widely used for cancer treatment and has non-negligible cardiotoxicity. Some previous studies have reported that cannabidiol (CBD) has cardioprotective effects. In this study, we evaluated the protective effects of CBD against DOX-induced cardiomyocyte injury, and explored the downstream molecular mechanism. Methods and Materials: GSE193861, containing healthy myocardial tissues and myocardial tissues with DOX-induced injury, was analyzed to screen for the involved proteins and pathways. Molecular docking was performed to identify candidate drugs. After H9c2 cells were treated with DOX and CBD, their viability, oxidative stress, and apoptosis were assessed. After YAP depletion, the role of the Hippo pathway in CBD function was investigated. C57BL/6 mice were treated with DOX to establish an in vivo model, and CBD and verteporfin (VP) were used to treat the mice. Histological analyses and immunofluorescence were used to evaluate myocardial tissue injury, and apoptosis and oxidative stress of the myocardial tissues were also analyzed. Western blotting was used to investigate the regulatory effects of CBD on the Hippo and apoptosis-related pathways. Results: Bioinformatic analysis suggested that the Hippo pathway was a crucial pathway involved in DOX-induced myocardial injury. Molecular docking showed that CBD targeted multiple regulators of the Hippo pathway. CBD showed cardioprotective effects against DOX-induced myocardial injury both in vitro and in vivo and regulated Hippo pathway activity in cardiomyocytes. After inactivation of the Hippo pathway by YAP knockdown or VP intervention, the protective effects of CBD were reversed. Conclusion: For the first time, we revealed that CBD is likely to reduce DOX-induced myocardial injury by regulating the Hippo signaling pathway.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2025) studied Doxorubicin-induced myocardial injury (n=40). Cannabidiol vs. Doxorubicin alone was evaluated on Myocardial injury, apoptosis, and oxidative stress. Cannabidiol reduced doxorubicin-induced myocardial injury, oxidative stress, and apoptosis in both in vitro and in vivo models by regulating the Hippo signaling pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: